Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.
Part of paid clinical trials in Cincinnati, Ohio.
- Sponsor
- University of Cincinnati
- Study ID
- NCT07313709
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Virtual Reality System — OTHERParticipants randomized to using VR-CRT will have the game already installed/uploaded in the VR headset and ready for use, with their pre-determined participant number for user login and password assigned.
- Word Search Puzzles — OTHERParticipants randomized to the control group will have their WSP packet with pre-selected word puzzles that provide a cognitive stimulus but without an increase in complexity. The instructions provided will state how participants should complete the WSP day-by-day. The dated completed WSPs, along with weekly check-ins by the study CRC will constitute the record for the participant's progress over four weeks. CRCs will notify the PI via email if during the call the participant indicates they have missed any of the WSPs during a given week.
Study Details
The study is focused on assessing the feasibility and effect of a virtual reality training intervention for improving the survivorship journey of brain cancer survivors, post-treatment. The gaming intervention is intended to reduce cognitive impairment, while increasing well-being, mental health, and quality of life.
Key Dates
- Start date
- Jan 1, 2026
- Status verified
- Oct 2025
- Primary completion
- Nov 1, 2026
- Completion
- May 1, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Experimental (Virtual Reality - VR)Experimental (VR) Participants ONLY: Participants randomized to using Virtual Reality-Cognitive Rehab Training (VR-CRT) will have the game already installed/uploaded in the VR headset and ready for use, with their pre-determined participant number for user login and password assigned.
- Active Comparator: Control (WSP)Control (WSP) Participants ONLY: Participants randomized to the control group will have their WSP packet with pre-selected word puzzles that provide a cognitive stimulus but without an increase in complexity. The instructions provided will state how participants should complete the WSP day-by-day. The dated completed WSPs, along with weekly check-ins by the study CRC will constitute the record for the participant's progress over four weeks. CRCs will notify the PI via email if during the call the participant indicates they have missed any of the WSPs during a given week.
Primary Outcome Measure
Feasibility defined as >80% (> 16 participants out of 20) able to complete the experimental arm study in 4 weeks. [ Time Frame: 4 weeks ]
Central Contacts
- UCCC Clinical Trials Office513-584-7698
- Anthony Faiola, PhD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | Anthony Faiola, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cincinnati, OH
By condition
By specialty
By research site
Related Studies
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-BeingNot Yet Recruiting · University of Colorado, Denver · Aurora, Colorado
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerPHASE2 · Recruiting · David W. Roberts · Lebanon, New Hampshire